Our results demonstrated that, compared to other groups, PDMP treatment decreased the number of CD133 and ALDH1 positive cells, suggesting the anti-tumor effect of PDMP may be due to the inhibition of CSCs. This evidence concerns the gene ALDH1A1 and neoplasm.